Business Today
Subscribe
PMS TodayBudget 2025US NewsIndiaWeatherBT ShortsNRIEducationElection
BT GolfBT India 100BT Mindrush
Search
Advertisement
Business News
markets
stocks
Bal Pharma Ltd
Bal Pharma Ltd

Bal Pharma Ltd (BALPHARMA) Share Price

  • Sector: Pharmaceuticals (Small Cap)
  • Volume: 11,111
Dec 05, 2025
  • NSE
  • BSE
Share
  • Whatsapp
  • Twitter
  • Facebook
₹71.47
₹-2.90 (-3.90%)
70.05Low
Today’s Performance
74.00High
70.05Low
52 Week’s Performance
132.00High

bt_logoStock Analysis

bt_logoStock Performance

  • 1 Day-3.90%
  • 1 Week-5.30%
  • 1 Month-11.06%
  • 3 Months-19.12%
  • 6 Months-28.07%
  • 1 Year-41.68%
  • 3 Years-7.35%
  • 5 Years4.36%

bt_logoStock Summary

  • Face Value (₹)10.00
  • Beta0.65
  • 52-Week Low (₹)70.05
  • 52-Week High (₹)132.00
  • Price-to-Book (X)*1.46
  • Dividend Yield (%)1.67
  • Price-to-Earnings (P/E) (X)*16.65
  • Earnings Per Share (₹)4.31
  • Market Cap (₹ Cr.)*113.79
* Values as of last close price

bt_logoCOMPETITORS

BT TV

"We Share, Not Just Sell”: Putin Reveals India–Russia Defence Upgrade & Nuclear Plans | Exclusive5:31"We Share, Not Just Sell”: Putin Reveals India–Russia Defence Upgrade & Nuclear Plans | Exclusive
Ground Report From IGI Counters: Stranded Flyers Slam IndiGo Amid Widespread Cancellations7:17Ground Report From IGI Counters: Stranded Flyers Slam IndiGo Amid Widespread Cancellations
FM Sitharaman Clarifies Cess On Demerit Goods: Fungible Funds For Defence, Public Health Support5:04FM Sitharaman Clarifies Cess On Demerit Goods: Fungible Funds For Defence, Public Health Support
India–Russia Trade to Cross $100 Billion Before 2030: PM Modi Fast-Tracks Economic Partnership2:31India–Russia Trade To Cross $100 Billion Before 2030: PM Modi Fast-Tracks Economic Partnership
Russia Eyes Indian Workforce, New Trade Plan And Tariff Cuts In Major Economic Push11:22Russia Eyes Indian Workforce, New Trade Plan And Tariff Cuts In Major Economic Push
IndiGo CEO Pieter Elbers Admits Worst-Ever Disruption As Over 1,000 Flights Cancelled Nationwide3:48IndiGo CEO Pieter Elbers Admits Worst-Ever Disruption As Over 1,000 Flights Cancelled Nationwide
India & Russia Plan Faster Trade Routes, Digital Corridors & New Nuclear Opportunities2:42India & Russia Plan Faster Trade Routes, Digital Corridors & New Nuclear Opportunities
Passengers Angry Over IndiGo Delays, Complain Of No Information3:16Passengers Angry Over IndiGo Delays, Complain Of No Information
Vikram Misri: India–Russia to Accelerate FTA, Investment Treaty and Key Connectivity Negotiations1:58Vikram Misri: India–Russia To Accelerate FTA, Investment Treaty And Key Connectivity Negotiations
‘If US Can Buy Russian Fuel, Why Not India?’: Putin Challenges Trump’s Claim On Ukraine War3:01‘If US Can Buy Russian Fuel, Why Not India?’: Putin Challenges Trump’s Claim On Ukraine War
View more

bt_logoFAQ's

What was Bal Pharma Ltd share price previously?
Bal Pharma Ltd share price was down by -3.90% from the previous closing price of ₹74.37.
Who are peers of Bal Pharma Ltd?
The peers of Bal Pharma Ltd are Sun Pharmaceutical Industries Ltd, Divis Laboratories Ltd, Torrent Pharmaceuticals Ltd, Cipla Ltd, Dr Reddys Laboratories Ltd, Lupin Ltd, Zydus Lifesciences Ltd.
Who is/are the promoter/promoters of Bal Pharma Ltd?
The promotor/promotors of Bal Pharma Ltd are Shailesh Siroya, Himesh Virupakshaya, H S Venkatesh, Nicola Neeladri, Jatish Sheth, Ravindrakumar Kothari, Abdul Basith.
What has been 52-week high of Bal Pharma Ltd stocks?
The highest price of Bal Pharma Ltd stock is ₹132.00 in the last 52-week.
What is the share price of Bal Pharma Ltd (BALPHARMA) today on NSE?
As on Dec 05, 2025 Bal Pharma Ltd (BALPHARMA)’s share price on NSE is Rs 71.47
What is the market cap of Bal Pharma Ltd (BALPHARMA)?
The current market capitalisation of Bal Pharma Ltd (BALPHARMA) is 113.79 crores
What is Bal Pharma Ltd Share symbol?
The symbol of Bal Pharma Ltd is BALPHARMA.
What is the PE ratio of Bal Pharma Ltd (BALPHARMA)?
The current PE ratio of Bal Pharma Ltd (BALPHARMA) is 16.65.
What is the PB ratio of Bal Pharma Ltd (BALPHARMA)?
The current PB ratio of Bal Pharma Ltd (BALPHARMA) is 1.46.
Today’s High & Low share prices of Bal Pharma Ltd (BALPHARMA) on NSE?
Today, the share price of Bal Pharma Ltd (BALPHARMA) on NSE touched a high of Rs 74 and a low of Rs 70.05
What price did Bal Pharma Ltd (BALPHARMA) shares open on the NSE today?
On NSE, the share price of Bal Pharma Ltd (BALPHARMA) opened at Rs 73.35
What is the 52-week high of Bal Pharma Ltd (BALPHARMA)?
The 52-week high price of Bal Pharma Ltd (BALPHARMA) is Rs 132.00
What is the 52-week low of Bal Pharma Ltd (BALPHARMA)?
The 52-week low price of Bal Pharma Ltd (BALPHARMA) is Rs 70.05

bt_logoAbout Bal Pharma

Bal Pharma Ltd, incorporated in the year 1987, has its registered office in 21 & 22 Bommasandra Indl Area, Hosur Road, Bangalore, Karnataka, 560092. The main industry in which Bal Pharma Ltd operates is Pharmaceuticals - Indian - Bulk Drugs & Formln.

Auditor/Auditors for Bal Pharma Ltd is/are SSJNB & Co. In the main management, is chairman and Abdul Basith is the company secretary for Bal Pharma Ltd.

  • SS
    Shailesh SiroyaED / MD / Promoter
  • HV
    Himesh VirupakshayaE D & Wholetime Director
  • HSV
    H S VenkateshIndependent Non Exe. Director
  • NN
    Nicola NeeladriIndependent Non Exe. Director
  • JS
    Jatish ShethIndependent Non Exe. Director
  • RK
    Ravindrakumar KothariIndependent Non Exe. Director
  • AB
    Abdul BasithCompany Sec. & Compli. Officer

bt_logoTop Stories

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.